The global Urea Breath Testing Market was valued at USD 480 million in 2025 and is projected to reach USD 895 million by 2035, growing at a CAGR of 6.20%, driven by rising H. pylori prevalence, non-invasive diagnostics, primary care adoption, and healthcare initiatives.

The global Infectious Disease Immunoassay Testing Market was valued at USD 8,850 million in 2025 and is projected to reach USD 13,480 million by 2035, growing at a CAGR of 4.30%, driven by ELISA, CLIA, rapid antigen tests, and POC diagnostics.

The global CLIA Endocrine Testing Market was valued at USD 7,320 million in 2025 and is projected to reach USD 14,600 million by 2035, growing at a CAGR of 7.06%, driven by diabetes, thyroid disorders, automation, and sensitive hormone testing.

The global Myocardial Infarction Therapeutic Market was valued at USD 8.21 million in 2025 and is projected to reach USD 12.95 million by 2035, growing at a CAGR of 4.66%, driven by cardiovascular disease burden and advances in diagnostics and treatment.

The global Immunoassay for Neurological Biomarkers Market was valued at USD 700 million in 2025 and is projected to reach USD 1,835 million by 2035, growing at a CAGR of 10.16%, driven by neurological disease diagnosis and ultrasensitive biomarker testing.

The global Infectious Disease Molecular Diagnostics Market was valued at USD 16.85 billion in 2025 and is projected to reach USD 30.35 billion by 2035, growing at a CAGR of 6.06%, driven by PCR, NGS, point-of-care testing, and disease surveillance.

The global Tissue Diagnostics Market was valued at USD 5.25 billion in 2025 and is projected to reach USD 9.58 billion by 2035, growing at a CAGR of 6.20%, driven by cancer incidence, IHC, ISH, companion diagnostics, and digital pathology.

The global Carrier Screening Market was valued at USD 1.72 billion in 2025 and is projected to reach USD 4.72 billion by 2035, growing at a CAGR of 10.61%, driven by NGS, expanded carrier screening, and prenatal genetic testing.

The global Recombinant Cell Culture Supplements Market was valued at USD 900 million in 2025 and is projected to reach USD 2,640 million by 2035, growing at a CAGR of 11.32%, driven by biopharmaceutical and GMP bioprocessing demand.

The global Lentiviral Vector Market was valued at USD 560 million in 2025 and is projected to reach USD 1,444 million by 2035, growing at a CAGR of 9.93%, driven by gene and cell therapy adoption.